EA201100951A1 - Пероральные диспергируемые таблетки - Google Patents

Пероральные диспергируемые таблетки

Info

Publication number
EA201100951A1
EA201100951A1 EA201100951A EA201100951A EA201100951A1 EA 201100951 A1 EA201100951 A1 EA 201100951A1 EA 201100951 A EA201100951 A EA 201100951A EA 201100951 A EA201100951 A EA 201100951A EA 201100951 A1 EA201100951 A1 EA 201100951A1
Authority
EA
Eurasian Patent Office
Prior art keywords
oral
dispensable tablets
dispensable
tablets
sugars
Prior art date
Application number
EA201100951A
Other languages
English (en)
Inventor
Свен Винтер
Макс-Вернер Шайве
Original Assignee
Рациофарм Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201100951(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Рациофарм Гмбх filed Critical Рациофарм Гмбх
Publication of EA201100951A1 publication Critical patent/EA201100951A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

В настоящем изобретении предлагается пероральная диспергируемая таблетка, включающая по крайней мере один наполнитель, выбранный из сахаров и сахарных спиртов, и микрокристаллическую целлюлозу.
EA201100951A 2008-12-19 2009-12-18 Пероральные диспергируемые таблетки EA201100951A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08022146A EP2198857A1 (en) 2008-12-19 2008-12-19 Oral dispersible tablet
PCT/EP2009/067511 WO2010070091A1 (en) 2008-12-19 2009-12-18 Oral dispersible tablet

Publications (1)

Publication Number Publication Date
EA201100951A1 true EA201100951A1 (ru) 2012-01-30

Family

ID=40567843

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201100951A EA201100951A1 (ru) 2008-12-19 2009-12-18 Пероральные диспергируемые таблетки

Country Status (6)

Country Link
US (1) US20110281912A1 (ru)
EP (2) EP2198857A1 (ru)
CA (1) CA2747679C (ru)
EA (1) EA201100951A1 (ru)
ES (1) ES2535015T3 (ru)
WO (1) WO2010070091A1 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013004123A (es) * 2010-10-12 2013-12-16 Univ Johns Hopkins Composiciones antitusigenas que comprenden memantina.
SG11201405053SA (en) * 2012-02-21 2014-09-26 Ranbaxy Lab Ltd Taste masked dispersible tablets
EP2866793A4 (en) * 2012-07-02 2016-07-27 Hetero Research Foundation SOLID ORAL COMPOSITIONS OF SILODOSINE
SI2719373T1 (sl) * 2012-10-12 2017-07-31 Omya International Ag Hitro razpadna trdna formulacijska dozirna oblika, ki vsebuje funkcionaliziran kalcijev karbonat in postopek za njeno izdelavo
JP2016504413A (ja) * 2013-01-15 2016-02-12 サン・ファーマシューティカルズ・インダストリーズ・リミテッド 安定な組成物を含有するフィンゴリモド
WO2014013090A2 (en) * 2013-05-06 2014-01-23 Synthon B.V. Formulation comprising amorphous fingolimod
EP2826465B1 (en) * 2013-07-19 2018-09-05 Sanovel Ilac Sanayi ve Ticaret A.S. Orally disintegrating tablet formulations of donepezil
IN2013MU02631A (ru) * 2013-08-12 2015-06-19 Genepharm India Pvt Ltd
EP3071182A1 (en) * 2013-11-18 2016-09-28 Sun Pharmaceutical Industries Ltd Oral dispersible composition of a dpp-iv inhibitor
US9925138B2 (en) 2015-01-20 2018-03-27 Handa Pharmaceuticals, Llc Stable solid fingolimod dosage forms
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2019029917A1 (en) * 2017-08-10 2019-02-14 Unilever N.V. COMPOSITION FOR ORAL CARE
CN110269844A (zh) * 2018-03-15 2019-09-24 互竑实业(上海)有限公司 一种基于喷墨3d打印奥氮平口崩片的制备方法
CN110613691A (zh) * 2018-06-19 2019-12-27 北京万全德众医药生物技术有限公司 一种含有peg-dspe-盐酸美金刚复合物的口崩片
BG67408B1 (bg) * 2019-04-12 2022-01-17 Софарма Ад Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости
TW202207940A (zh) * 2020-04-14 2022-03-01 美商健生生物科技公司 包含胺基嘧啶衍生物或其醫藥上可接受之鹽、水合物、或溶劑化物之用於經口投予之醫藥組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030868A1 (en) * 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
ES2199061B1 (es) 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
CN101115469A (zh) * 2004-12-28 2008-01-30 卫材R&D管理有限公司 速崩片及其制造方法
EP1681048A1 (en) 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Orally disintegrating composition of olanzapine or donepezil
IS7724A (is) * 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
CA2612917A1 (en) * 2005-06-23 2007-01-04 Schering Corporation Rapidly absorbing oral formulations of pde5 inhibitors
JP5209966B2 (ja) 2005-09-01 2013-06-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 崩壊性の改善された医薬組成物の製造方法
US8048449B2 (en) 2005-12-27 2011-11-01 Jubilant Organosys Ltd. Mouth dissolving pharmaceutical composition and process for preparing the same
NZ572106A (en) 2006-03-31 2010-12-24 Rubicon Res Private Ltd Directly compressible composite for orally disintegrating tablets
WO2008057267A2 (en) 2006-10-27 2008-05-15 Fmc Corporation Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations

Also Published As

Publication number Publication date
US20110281912A1 (en) 2011-11-17
WO2010070091A1 (en) 2010-06-24
CA2747679C (en) 2016-08-23
EP2198857A1 (en) 2010-06-23
ES2535015T3 (es) 2015-05-04
EP2367540A1 (en) 2011-09-28
CA2747679A1 (en) 2010-06-24
EP2367540B1 (en) 2015-03-25

Similar Documents

Publication Publication Date Title
EA201100951A1 (ru) Пероральные диспергируемые таблетки
CL2013001586A1 (es) Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion.
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
AP2274A (en) Alcohol resistant dosage forms.
DK1863526T3 (da) Levende, attenueret rotavirusvaccine til oral indgivelse
DK3984528T3 (da) Farmaceutiske sammensætninger, som omfatter nilotinib
ES2352576T8 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana.
ZA200709516B (en) C. perfringens alpha toxoid vaccine
FR2936709B1 (fr) Comprimes alcoolo-resistants.
EP2251005A4 (en) TABLETS OFFERING ORALLY
IT1397663B1 (it) Bocchettone e procedimento per la sua fabbricazione.
WO2008066784A3 (en) Expression of foxp3 by cancer cells
IL213247A0 (en) Ulipristal acetate tablets
MX2009003323A (es) Eteres de celulosa cuaternizados para productos para el cuidado personal.
PL2356989T3 (pl) Trwała tabletka zawierająca pochodną 4,5-epoksymorfinanu
CL2007003593A1 (es) Composicion farmaceutica que comprende fluoresceina pura; procedimiento de preparacion de la fluoresceina.
BRPI0922442A2 (pt) Transformação de cana-de-açúcar.
ITMI20050357A1 (it) Procedimento di preparazione del tazarotene
WO2010081722A3 (en) Orally disintegrating tablets for the treatment of pain
TR200909786A1 (tr) Sefiksim içeren efervesan tablet ve granül formülasyonu.
BRPI0815562A2 (pt) Soluções farmacêuticas orais contendo telbivudina.
ITFI20080016A1 (it) Formulazioni farmaceutiche orali contenenti gliclazide.
BRPI0919168A2 (pt) pestivírus mutante, e, vacina.
UA41849U (en) Enterosorbent
ITCE20040004A1 (it) Pneumocestello per la cattura dei calcoli del coledoco.